P
Prime Medicine, Inc.
PRME · NASDAQ · Healthcare · 558M
Price · close
$3.39
+4.63% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.2×
Enterprise value / EBITDAEV/EBITDA
-2.8×
Free cash flow yieldFCF yield
-33.1%
Return on equityROE
-166.4%
Operating margin
-4498.1%
Net debt / EBITDAbalance-sheet strength
-0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.